MRI enteroclysis is an advanced MRI technique for detailed small-bowel imaging where a thin tube is passed through the nose into the small intestine to infuse contrast and distend the bowel. It produces high-resolution, radiation-free images of bowel wall and surrounding structures, improving detection of Crohn’s disease, strictures, tumors, and fistulae. Requires bowel preparation and may cause brief discomfort from tube placement.

Enteroclysis is a specialized imaging test of the small intestine in which a thin tube is passed through the nose or mouth into the small bowel and contrast fluid is directly infused while fluoroscopic or CT images are taken. It gives detailed views to diagnose strictures, Crohn’s disease, obstructions or malabsorption. Preparation includes fasting; risks include discomfort, radiation exposure and rare perforation or allergic reaction.

Enteroclysis is usually uncomfortable rather than severely painful. Tube insertion can cause gagging, throat soreness and brief discomfort; during the exam you may feel cramping, bloating or nausea as contrast distends the small bowel. Most people tolerate it without general anaesthesia; severe pain is uncommon. Tell staff if pain is intense—they can modify the procedure or offer sedatives/analgesics.

Enteroclysis risks include radiation exposure and contrast-related reactions (nausea, vomiting, rare iodine allergy). Tube placement can cause discomfort, nasal or throat trauma, aspiration, or very rarely bowel perforation. Barium may cause abdominal pain, cramping, constipation or impaction; infection and bleeding at insertion are uncommon. Serious complications are rare—inform clinicians about pregnancy, allergies, or known bowel disease.

Ileocolonoscopy with biopsy is the diagnostic gold standard for confirming Crohn’s disease. It allows direct visualization of characteristic features (skip lesions, ulcers, strictures) and tissue sampling; histological findings such as transmural inflammation and granulomas provide definitive proof. Supportive tests include CT/MR enterography, small‑bowel imaging, stool calprotectin and blood tests, but biopsy‑proven histology confirms the diagnosis.

Enteroclysis is highly accurate for detecting small‑bowel structural disease (strictures, masses, obstructions), generally outperforming small‑bowel follow‑through. Reported sensitivity and specificity for major lesions commonly fall in the ~80–95% range. Accuracy varies with technique (CT/MR vs fluoroscopy), operator, and lesion type; small superficial mucosal lesions can be missed. It’s more invasive and may involve radiation (CT) and patient discomfort.